Our collaborative approach begins with a thorough analysis of your strengths and potential, allowing us to prioritize and address your unique challenges effectively. 

We assist in implementing innovative business, sales, and distribution models, mitigating the risks associated with rising R&D costs through early study planning. 

Additionally, we provide expert support to navigate patent expiry issues and the complexities of Biosimilars, ensuring your business remains competitive and resilient in the ever-evolving market landscape.

Our Market Access support encompasses a comprehensive range of services for pharmaceuticals, medical devices, vaccines, and biotech.

This ensures the successful reimbursement of new products in both inpatient and outpatient settings. 

We assist with NUB applications, DRG workshops, and OPS code applications, and develop internationally harmonized Market Access strategies. 

Our services include reference pricing analysis, creating contracting models with payers and insurance companies, and organizing 'Sounding Boards' for engaging discussions with decision-makers and stakeholders. 

We also provide tailored training and support during negotiations and decision-making processes, along with ongoing monitoring and evaluation of results to ensure success.

Our Market Access support offers several key benefits:

• Faster access to markets through recognition of added therapeutic benefits
• Improved reimbursement terms via effective price and negotiation strategies
• A broader customer base by clearly communicating value arguments
• Better long-term results through comprehensive lifecycle management, strategic contracting, patient management pathways, and robust compliance management